1,040
Participants
Start Date
November 30, 2003
Study Completion Date
January 31, 2006
rivastigmine transdermal patch
Greensburg
Snellville
Miami
Miami Beach
Fort Lauderdale
West Palm Beach
Boca Raton
Port Charlotte
Nashville
Columbus
Dayton
St Louis
Omaha
Oklahoma City
Houston
Austin
San Francisco
Tacoma
Orange
Long Branch
Toms River
Whiting
Santiago
Valparaíso
Brno
Brno-Bohunice
Hradec Králové
Olomouc
Prague
Copenhagen
Glostrup Municipality
Hillerød
Kuopio
Investigative Sites
Guatemala City
Beersheva
Haifa
Jerusalem
Petah Tikva
Tel Aviv
Lido di Camaiore
Milan
Pescara
Guadalajara Jalisco
Mexico City
Monterrey Nuevo Leon
Bodø
Oslo
Tromsø
Trondheim
Lima
Gdansk
Lublin
Poznan
Szczecin
Warsaw
Amadora
Coimbra
Moscow
Saint Petersburg
Bratislava
Michalovce
Jungbuk
KyungKi-province
Seoul
Gothenburg
Kalmar
Stockholm
Uppsala
Kaohsiung City
Taichung
Taipei
Taoyuan District
Ciudad Merida
Bayamón
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY